Top compounds associated with response to TLDC2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA PD-0325901 CCLE pan-cancer AAC 0.15 0.0005
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA YM-155 CTRPv2 pan-cancer AAC -0.14 0.0006
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.2 0.0008
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.12 0.0008
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.12 0.001
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV